As previously stated, myeloid cells have been known to contribute to a pro-angiogenic environment, however, the CD11b+ subset also has been widely associated with inflammation and anti-tumor immunosuppression mechanisms involved with malignant gliomas, notably GBM [21], implicating it as a potentially significant factor in malignant progression. Here, ITGAM is linked to glioblastoma.